Semaglutide Shows Benefits for PAD Across T2D Subgroups ...Middle East

Medscape - News
Semaglutide Shows Benefits for PAD Across T2D Subgroups
A post-hoc analysis of STRIDE confirms the benefit of GLP-1 RA in patients with peripheral arterial disease and type 2 diabetes, but more research is needed in those without diabetes. Medscape Medical News

Hence then, the article about semaglutide shows benefits for pad across t2d subgroups was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Semaglutide Shows Benefits for PAD Across T2D Subgroups )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News